Evidence map›Paper›PMID 34079764›Full record

ReviewFrontiers in oncology2021

Has COVID-19 Affected Cancer Screening Programs? A Systematic Review.

Ibrahim Alkatout, Matthias Biebl, Zohre Momenimovahed, Edward Giovannucci, Fatemeh Hadavandsiri, Hamid Salehiniya, Leila Allahqoli

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04683744 (Facilitators and Barriers to Cancer Screening), which is not on this map. Cited by 88 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 6 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04683744 completednot on this map

Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation

TypeobservationalSponsorIndiana UniversityRan2021 to 2023Enrolled82ConditionsColorectal Cancer ScreeningArmsSemi-structured interviews-Patients, Semi-structured interviews-Health system
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 6 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Changes in chronic disease prevention resources and activities in Canada during the COVID-19 pandemic.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 3 countries.

Ibrahim AlkatoutKiel School of Gynaecological Endoscopy, University Hospitals Schleswig-Holstein, Kiel, Germany.
Matthias BieblDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Zohre MomenimovahedDepartment of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran.
Edward GiovannucciDepartments of Nutrition and Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United States.
Fatemeh HadavandsiriCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamid SalehiniyaSocial Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Leila AllahqoliSchool of Public Health, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Birjand University of Medical Sciences · IRBrigham and Women's Hospital · USCharité - Universitätsmedizin Berlin · DEIran University of Medical Sciences · IRQom University of Medical Science and Health Services · IRShahid Beheshti University of Medical Sciences · IRUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth care services across the world have been enormously affected by the onset of the coronavirus disease 2019 (COVID-19). Services in oncology have been curtailed because medical services have been focused on preventing the spread of the virus and maximizing the number of available hospital beds. The present study was designed to investigate the impact of COVID-19 on cancer screening.

methodsDatabases such as Medline, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A & HCI Timespan) and Scopus were searched comprehensively for articles published until January 2021. The keywords used were COVID-19 and

resultsThe review comprised 17 publications. The impact of COVID-19 was categorized into four dimensions: a significant decline in cancer screening and pathology samples, the cancer diagnosis rate, an increase in advanced cancers, mortality rate and years of life lost (YLLs).

conclusionCancer screening programs have been clearly interrupted since the onset of the COVID-19 disease. The anticipated outcomes include delayed diagnosis and marked increases in the numbers of avoidable cancer deaths. Urgent policy interventions are needed to handle the backlog of routine diagnostic services and minimize the harmful effects of the COVID-19 pandemic on cancer patients.

Indexed as

cancercoronavirus disease 2019 (COVID-19)diagnosishealth carescreening

Identifiers

PMID34079764
PMCPMC8165307
OpenAlexW3160302140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.